For dry powder inhaled formulations, good flow behaviour is vital in re-dispersing the powder. However, inhaled drug powders with a particle size below 10 µm are classified as highly cohesive materials with poor flow characteristics. Here we demonstrate how to alter the flow properties of micronized budesonide powders by depositing different materials (organic, inorganic, and hybrid organic–inorganic) in the forms of nanoscale films onto the drug particles using atomic/molecular layer deposition (ALD/MLD) coatings. The angle of repose (static) and pneumatic delivery measurements were performed to access the flow characteristics. The flowability can be effectively improved with the growth of inorganic nanofilm (SiO₂, TiO₂, or Al₂O₃) via ALD and hybrid nanofilm (titanicone) via combined ALD-MLD coating. This improvement is reflected by the decrease in the angle of repose and minimum pick-up velocity (U_pu), as well as promoting the pneumatic delivery of a much larger amount of drug powders after ALD or hybrid coating. In contrast, the organic PET coated budesonide via MLD exhibits comparable poor flow characteristics as the uncoated budesonide. Rather than being transported in individual particles, the uncoated or PET-coated budesonide powders are pneumatically delivered in form of complex clusters with a size of over 500 μm, whereas the ALD budesonide is dispersed in form of small agglomerates (<100 μm). Despite the difference in agglomerate size, entraining behaviors of all samples agree well with the prediction of Kalman's pick-up Zone I correlation. The inorganic nanofilm deposited via ALD alters the surface chemistry to reduce the inter-particle forces measured by atomic force microscopy, giving rise to an improved drug delivery performance. Nanoscale surface modification of dry powder particles has good potential for inhaled drug delivery enhancement.

@en

Polymer nanocomposites (NCs) offer outstanding potential for dielectric applications including insulation materials. The large interfacial area introduced by the nanoscale fillers plays a major role in improving the dielectric properties of NCs. Therefore, an effort to tailor the properties of these interfaces can lead to substantial improvement of the material’s macroscopic dielectric response. Grafting electrically active functional groups to the surface of nanoparticles (NPs) in a controlled manner can yield reproducible alterations in charge trapping and transport as well as space charge phenomena in nanodielectrics. In the present study, fumed silica NPs are surface modified with polyurea from phenyl diisocyanate (PDIC) and ethylenediamine (ED) via molecular layer deposition (MLD) in a fluidized bed. The modified NPs are then incorporated into a polymer blend based on polypropylene (PP)/ethylene-octene-copolymer (EOC), and their morphological and dielectric properties are investigated. We demonstrate the alterations in the electronic structure of silica upon depositing urea units using density functional theory (DFT) calculations. Subsequently, the effect of urea functionalization on the dielectric properties of NCs is studied using thermally stimulated depolarization current (TSDC) and broadband dielectric spectroscopy (BDS) methods. The DFT calculations reveal the contribution of both shallow and deep traps upon deposition of urea units onto the NPs. It could be concluded that the deposition of polyurea on NPs results in a bi-modal distribution of trap depths that are related to each monomer in the urea units and can lead to a reduction of space charge formation at filler-polymer interfaces. MLD offers a promising tool for tailoring the interfacial interactions in dielectric NCs.

@en

We show the potential of coupling numerical and experimental approaches in the fundamental understanding of catalytic reactors, and in particular fluidized beds. The applicability of the method was demonstrated in a lab-scale fluidized bed reactor for the platinum-based catalytic oxidation of hydrogen. An experimental campaign has been carried out for synthesizing the catalyst powders by means of atomic layer deposition in a fluidized bed reactor and characterizing them. Catalytic testing has been also run to collect data both in fixed and fluidized bed configurations. Then, after the validation of the in-house first-principles multiscale Computational Fluid Dynamic - Discrete Element Method (CFD-DEM) model, the fundamental understanding which can be achieved by means of detailed numerical approaches is reported. Thus, the developed framework, coupled with experimental information, results in an optimal design and scale-up procedure for reactor configurations promising for the energy transition.

@en

The majority of pharmaceutical products is made of solid powders. The morphology and surface characteristics of drug particles affect both their bulk behaviour, e.g., flowability, dispersibility and tabletability, in the manufacturing process of dosage forms as well as their bioavailability upon administration into the human body. For instance, in pulmonary drug delivery, particles with an aerodynamic diameter <5 µm are required to reach the action sites of the lungs. Surface modification provides the means to tailor crucial functionalities of pharmaceutical particles, such as dissolution, wettability, flowability and dispersibility, based on the desired formulation design. Atomic layer deposition (ALD) and molecular layer deposition (MLD) are gas-phase film technologies that enable atomic-level control over surface properties through the fabrication of nanoscale films on individual particles, which impact the powder performance. The benefits of ALD and MLD for pharmaceuticals compared to existing surface modification techniques include (i) gas-phase and fully solventless nature of the process, (ii) wide range of process conditions, including low temperature and atmospheric pressure, (iii) control over the amount of deposited material and film thickness in the sub-nanometer and low-nanometer range, (iv) high drug loadings due to the nanoscale films, (v) uniform and conformal films, crucial for tailored functional properties. Moreover, the possibility to carry out ALD and MLD in fluidized bed reactors offers scalable processing and manufacturing of bulk quantities of nano-engineered powders, relevant for pharmaceutical applications. This thesis deals with the development of ALD and MLD processes on excipient and drug particles, especially for pulmonary delivery, to control their release and enhance their dispersibility and flowability.@en

Nanoencapsulated phase-change materials (nePCMs) are investigated for enhancing thermal energy storage. However, the shell of these nanocapsules may fail due to stress developed during thermal processes, leading to melting enthalpy loss. To overcome this problem, SiO₂ and Al₂O₃ coatings on Sn nanoparticles are synthesized by atomic layer deposition (ALD). To study the influence of shell thickness and composition on the probability of failure (POF) of nePCM shells in single- and multicoated nePCMs, a probabilistic numerical tool combining Monte Carlo techniques and a thermomechanical finite-element model with phase change are used. The uncertainties of the material and geometrical properties of nePCMs are included in the analysis. Both deterministic and probabilistic failure criteria are taken into account to consider the effect of dispersion on tensile strength. The results indicate that multicoated nePCMs enhance thermomechanical performance in relation to their single-coated counterparts. Both the numerical simulations and experiments confirm that the POF of nePCM shells and melting enthalpy loss in multicoated nePCMs lower with shell thickness. The results after 50 ALD cycles indicate that Al₂O₃ coatings exhibit better performance because a POF of 1.66% is obtained with 1.1% enthalpy loss, while the POF for SiO₂ is 72.38% with 3.5% enthalpy loss.

@en

Fluidization of cohesive pharmaceutical powders is difficult to achieve and typically requires the introduction of external forces. This study investigates the fluidization of the fine inhalation grade of lactose powders (size range from 0.1-20 μm) that are specifically developed for dry powder inhalation (DPI) applications. The fluidization behaviour of fine lactose powders was evaluated under six conditions: without fluidization aids, with only vertical vibration (VFA), with only a downward-pointing micro-jet (MFA), with both vibration and pre-mixing with coarse particles (VCFA), with both vibration and micro-jet (VMFA), and with the combined assistance of vibration, micro-jet, and addition of coarse particles (VMCFA). The enhancement of fluidization due to the use of different assistance methods is reflected by the increase of bed expansion and the decrease in both the minimum fluidization velocity and agglomerate formation. However, applying micro-jet results in considerable powder losses due to the high fraction of fine particles stuck to the wall. Combining any two assisting methods leads to better fluidization than using a single approach. In particular, the combination of vibration and micro-jet shows the best performance in improving fluidization. Further addition of coarse particles does not play a significant influence on promoting fluidization. Finally, the analysis of the forces acting on the lactose agglomerates shows the enhancement of separation forces by introducing the fluidization assistance, which leads to a decrease in agglomerate size.

@en

Ideal controlled pulmonary drug delivery systems provide sustained release by retarding lung clearance mechanisms and efficient lung deposition to maintain therapeutic concentrations over prolonged time. Here, we use atomic layer deposition (ALD) to simultaneously tailor the release and aerosolization properties of inhaled drug particles without the need for lactose carrier. In particular, we deposit uniform nanoscale oxide ceramic films, such as Al2O3, TiO2, and SiO2, on micronized budesonide particles, a common active pharmaceutical ingredient for the treatment of respiratory diseases. In vitro dissolution and ex vivo isolated perfused rat lung tests demonstrate dramatically slowed release with increasing nanofilm thickness, regardless of the nature of the material. Ex situ transmission electron microscopy at various stages during dissolution unravels mostly intact nanofilms, suggesting that the release mechanism mainly involves the transport of dissolution media through the ALD films. Furthermore, in vitro aerosolization testing by fast screening impactor shows a μ2-fold increase in fine particle fraction (FPF) for each ALD-coated budesonide formulation after 10 ALD process cycles, also applying very low patient inspiratory pressures. The higher FPFs after the ALD process are attributed to the reduction in the interparticle force arising from the ceramic surfaces, as evidenced by atomic force microscopy measurements. Finally, cell viability, cytokine release, and tissue morphology analyses verify a safe and efficacious use of ALD-coated budesonide particles at the cellular level. Therefore, surface nanoengineering by ALD is highly promising in providing the next generation of inhaled formulations with tailored characteristics of drug release and lung deposition, thereby enhancing controlled pulmonary delivery opportunities.

@en

Functionalized nanoparticles have various applications, for which grafting of a chemical moiety onto the surface to induce/improve certain properties is needed. When incorporated in polymeric matrices, for instance, the modified nanoparticles can alter the interfacial characteristics leading to improvements ofthe macroscopic properties of the nanocomposites. The extent of these improvements is highly dependent on the thickness, morphology and conformity of the grafted layer. However, the common liquid-phase modification methods provide limited control over these factors. A novel gas-phase modification process was utilized, with 3-aminopropyltriethoxysilane (APTES) as precursor, to chemically deposit amino-terminated organic layers on fumed silica nanoparticles in a fluidized bed. A self-limiting surface saturation was achieved when the reaction was done at 200 °C. With this self-limiting feature, we were able to graft multiple layers of aminopropylsiloxane (APS) onto the silica nanoparticles using water as the coreactant. The feasibility of this process was analyzed using thermogravimetric analysis (TGA), diffuse reflectance IR Fourier transform spectroscopy (DRIFTS), X-ray photoelectron spectroscopy (XPS), and elemental analysis (EA). By altering the number of APTES/water cycles, it was possible to control the thickness and conformity of the deposited aminopropylsiloxane layer. This novel approach allows to engineer the surface of nanoparticles, by introducing versatile functionalized layers in a controlled manner.

@en

The wettability of pharmaceuticals is a key physical property which influences their dissolution rate, dispersibility, flowability and solid-state stability. Here, we provide a platform of surface nanoengineering methods capable of tuning the wettability of drug powders from high hydrophilicity to superhydrophobicity with drug loadings up to 95–99%. Specifically, we functionalize gram-scale micronized budesonide, a commercial active pharmaceutical ingredient for respiratory diseases, in a vibrated fluidized bed reactor with inorganic Al₂O₃, TiO₂ and SiO₂ by atomic layer deposition (ALD), organic poly(ethylene terephthalate) (PET) by molecular layer deposition (MLD) and inorganic/organic titanicone by hybrid ALD/MLD. Transmission electron microscopy shows the formation of smooth and uniform films for each deposition process without significantly affecting the surface morphology of the budesonide particles. Crucially, the deposition processes do not alter the solid-state structure and cytocompatibility of budesonide. The ceramic ALD films are able to convert the originally hydrophobic budesonide into highly hydrophilic powders with water contact angles (WCAs) of ~10° within a few seconds. The purely organic PET films grown via MLD deliver superhydrophobic powders with a WCA of 145–150°. In contrast, the titanicone hybrid ALD/MLD films lead to mild hydrophilicity with WCAs ranging from ~80° to ~60°. Modifying the wetting properties of inhaled drug powders such as budesonide is relevant to improve bioavailability, enhance the dispersion of formulations in suspension-based inhalers or prevent moisture interactions in dry powder inhalers. Moreover, by tuning the surface chemical composition at the atomic or molecular level, particle ALD, MLD and hybrid ALD/MLD enable control over powder wettability for several pharmaceutical dosage forms with applications in oral, orally inhaled and parenteral delivery.

@en

Nanoencapsulated phase change materials (nePCMs) are nowadays under research for thermal energy storage purposes. NePCMs are composed of a phase change core surrounded by a shell that confines the core when molten. One of the main concerns of nePCMs when subjected to thermal processes is the mechanical failure of the passivation shell initially present in commercial metallic nanoparticles. In order to overcome this issue, multi-coated nePCMs, based on the synthesis of an additional coating by atomic layer deposition, appear to be as a candidate solution. With the objective of studying the influence of the composition and thickness of the additional nePCM shells on their probability of failure, a numerical tool combining a thermomechanical finite element model with phase change and Monte Carlo algorithms is developed. This tool also allows including the uncertainty of material and geometrical properties into the numerical analysis to account for their influence in the mechanical performance of nePCMs. In the present work, the mechanical reliability of SiO₂ and Al₂O₃ coatings on Sn@SnO_x nanoparticles is assessed by considering both deterministic and probabilistic failure criteria and Al₂O₃ coatings appear to have a better mechanical performance than their SiO₂ counterparts.

@en

The development of advanced heat transfer fluids (HTF) with enhanced heat transfer properties has been identified as a key target to increase the efficiency of industrial processes. In this work, heat transfer performance improvements of a novel nanofluid, consisting of metallic nanoparticles dispersed in a commercial thermal oil, were investigated. Nanofluids combining tin nanoparticles (1 mass %) with Therminol 66 (TH66) were synthesised using the two step-method and experimentally analysed. The effectiveness of biosurfactant addition and nanoparticle polyethylene terephthalate (PET) nanocoating for high temperature nanofluid stabilisation were independently investigated. The PET nanoscale coatings were grown by molecular layer deposition, which has been used for the first time in this field. The thermal conductivity, dynamic viscosity and specific heat capacity of the stable, oil-based nanofluids were characterised at high temperatures, and the results were compared and in good agreement with models found in the relevant literature. Finally, the heat transfer performance of the nanofluids with respect to their base fluids was evaluated, employing empirical values for the thermophysical properties of the involved materials. In this way, increments of the heat transfer coefficients up to 9.3% at 140 °C, relevant to industrial applications were obtained.

@en

Renewable energy has become of great interest over the past years in order to mitigate Global Warming. One of the actions gaining attention is the enhancement of the thermal energy storage capacity of Concentrated Solar Power plants. The addition of nanoencapsulated phase change materials (core-shell nanoparticles) to the already used materials has been proposed for that purpose, due to the possibility of increasing thermal storage through the contribution of both core latent heat and sensible heat. In this work, Atomic Layer Deposition has been used to synthesise SiO₂ and Al₂O₃ nanoscale coatings on tin nanoparticles. The multi-encapsulated phase change materials have been characterised in terms of chemical composition, crystalline structure, particle size, thermal stability and thermal storage capacity. Sn@Al₂O₃ nanoparticles present the best thermal behaviour as they show the lowest reduction in the phase change enthalpy over 100 cycles due to the oxidation barrier of the coating. Moreover, the specific heat of both nanoparticles and solar salt-based nanofluids is increased, making the nanoencapsulated phase change material suitable for thermal energy storage applications.

@en

In this work, we report molecular layer deposition (MLD) of ultrathin poly(ethylene terephthalate) (PET) films on gram-scale batches of ultrafine particles for the first time. TiO2 P25 nanoparticles (NPs) are coated up to 50 cycles in an atmospheric-pressure fluidized-bed reactor at 150 °C using terephthaloyl chloride and ethylene glycol as precursors. Ex-situ diffuse reflectance infrared Fourier transform spectroscopy, thermogravimetric analysis, and transmission electron microscopy show the linear growth at 0.05 nm/cycle of uniform and conformal PET films, which are unattainable with conventional wet-phase approaches. The sub-nanoscale and nanoscale PET films not only suppress the photocatalytic activity of TiO2 NPs by hindering the access of water and reactant molecules to the TiO2 surface but also improve the dispersibility of TiO2 NPs in both organic and aqueous media. Still, the bulk optical properties, electronic structure, and surface area of TiO2 are essentially unaffected by the MLD process. This study demonstrates the industrial relevance of MLD to simultaneously suppress the photoactivity and enhance the dispersibility of commercial TiO2 P25 nanopowders, which is crucial for their use for example as UV-screening agents in sunscreens and as white pigments in paints. Moreover, by rapidly modifying the surface properties of particles in a controlled manner at the sub-nanometer scale, particle MLD can serve many other applications ranging from nanofluids to emulsions to polymer nanocomposites.

@en

We employed atomic layer deposition (ALD) to deposit ultrathin SiO₂ layers on P25 TiO₂ nanoparticles to fabricate TiO₂/SiO₂ core/shell nanostructures. The ALD process was carried out in a fluidized bed reactor working at atmospheric pressure using SiCl₄ and H₂O as precursors, enabling the deposition of SiO₂ at 100 °C with the ability to control the thickness at the sub-nanometer level. By controlling the thickness of the SiO₂ in a very narrow range, i.e., below 2 nm, the photocatalytic activity of TiO₂ can be tuned. In particular, an enhancement was obtained for the SiO₂ layers with a thickness below 1.4 nm, in which the layer with a thickness of about 0.7 nm exhibited the highest photocatalytic activity; for SiO₂ layers thicker than 1.4 nm, the photocatalytic activity was strongly suppressed. The photocatalytic activity enhancement and the degradation mechanism of RhB by the TiO₂/SiO₂ photocatalysts were investigated by combining X-ray photoelectron spectroscopy, UV–Vis absorption spectroscopy, photoluminescence spectroscopy and the aid of charge carrier and radical scavengers. Our findings have revealed an improvement of photogenerated charge separation due to the SiO₂ coating and the dominating role of hydroxyl radicals in the degradation of RhB.

@en

The morphology, size, and surface properties of pharmaceutical particles form an essential role in the therapeutic performance of active pharmaceutical ingredients (APIs) and excipients as constituents in various drug delivery systems and clinical applications. Recent advances in methods for surface modification, however, rely heavily on liquid-phase-based modification processes and afford limited control over the thickness and conformality of the coating. Atomic layer deposition (ALD), on the other hand, enables the formation of conformal nanoscale films on complex structures with thickness control on the molecular level, while maintaining the substrate particle size and morphology. Moreover, this enables nanoengineering of surfaces of pharmaceutical particles also in the dry state. Successful nanoengineeering of crystal and amorphous surfaces of pharmaceutical particles is demonstrated in this study whereby functional properties, such as dissolution and dispersibility, were tailored for drug delivery applications. This expands on our initial work on ALD of alumina on pharmaceutical particles within the lower micro- to higher nanosize ranges to here probe both crystalline and amorphous lactose substrate surfaces (d₅₀ = 3.5 and 21 μm). In addition, both water and ozone coreactants were evaluated, the latter having not been evaluated previously for pharmaceutical particles. The deposition process is carried out at ambient conditions in a fluidized bed reactor for a low number of cycles (i.e., from 4 to 14). Improved dissolution and extended release were achieved by the ALD nanoengineering of both crystalline and amorphous surfaces. This novel concept opens up exciting opportunities to produce more complex materials and structures using temperature- and moisture-sensitive drugs, e.g., targeting and drug delivery opportunities, as well as delivering new functionalities for novel applications in the pharmaceutical, medical, biological, and advanced materials fields. The prospects for advancing inhaled drug delivery are exemplified by the ALD surface nanoengineering concept.

@en

A fundamental understanding of the interplay between ligand-removal kinetics and metal aggregation during the formation of platinum nanoparticles (NPs) in atomic layer deposition of Pt on TiO₂ nanopowder using trimethyl(methylcyclo-pentadienyl)platinum(IV) as the precursor and O₂ as the coreactant is presented. The growth follows a pathway from single atoms to NPs as a function of the oxygen exposure (P_O2 × time). The growth kinetics is modeled by accounting for the autocatalytic combustion of the precursor ligands via a variant of the Finke–Watzky two-step model. Even at relatively high oxygen exposures (<120 mbar s) little to no Pt is deposited after the first cycle and most of the Pt is atomically dispersed. Increasing the oxygen exposure above 120 mbar s results in a rapid increase in the Pt loading, which saturates at exposures >> 120 mbar s. The deposition of more Pt leads to the formation of NPs that can be as large as 6 nm. Crucially, high P_O2 (≥5 mbar) hinders metal aggregation, thus leading to narrow particle size distributions. The results show that ALD of Pt NPs is reproducible across small and large surface areas if the precursor ligands are removed at high P_O2.

@en

Understanding the spontaneous organization of atoms on well-defined surfaces promises to enable control over the shape and size of supported nanostructures. Atomic layer deposition (ALD) boasts atomic-scale control in the synthesis of thin films and nanoparticles. Yet, the possibility to control the shape of ALD-grown nanostructures remains mostly unexplored. Here, we report on the bottom-up formation of both linear and V-shaped anatase TiO₂ nanorods (NRs) on graphene nanoplatelets during TiCl₄/H₂O ALD carried out at 300 °C. NRs as large as 200 nm form after only five ALD cycles, indicating that diffusional processes rather than layer-by-layer growth are behind the NR formation. In particular, high-resolution transmission electron microscopy reveals that the TiO₂ NRs and graphene nanoplatelets are in rotational alignment as a result of lattice matching. Crucially, we also show that individual nanocrystals can undergo in-plane oriented attachment.

@en